Skip Navigation

About the Journal

Annals of Oncology, the journal of the European Society of Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

With a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.

Indexing

Annals Of Oncology is covered by the following major indexing services:

CAB Abstracts
Current Contents® /Clinical Medicine
Elsevier BIOBASE - Current Awareness in Biological Sciences (CABS)
EMBASE
Journal Citation Reports /Science Edition
PROQUEST
Prous Science Integrity®
PubMed
Science Citation Index Expanded (SciSearch®)
Science Citation Index®

IMPACT FACTOR AND RANKING


YearImpact FactorSi: Oncology
20127.38418 out of 196
20116.42517 out of 194
20106.45220 out of 184
20095.64719 out of 165
20084.93526 out of 141
20074.87523 out of 132
20065.17921 out of 127

This information is taken from the Journal Citation Reports, published annually as part of the Science Citation Index by ISI.